Pharmaceuticals News

Hemp Hop THCa dispensary extends pickup and Charlotte delivery to 11 PM daily, with third party lab testing, COAs and discreet nationwide shipping.

BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a clinical-stage biotechnology company pioneering cellular rejuvenation medicines to reverse diseases of aging, today...

BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL) (“Replimune”), a commercial-stage biotechnology company pioneering the development of novel oncolytic immunotherapies,...

SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced...

Peer-reviewed preclinical data demonstrate that Telomir-Zn suppresses tumor growth through iron modulation in TNBC and prostate cancer models.

Phase 1 study conducted by Memorial Sloan Kettering (“MSK”) Cancer Center and funded by The Lustgarten FoundationStudy to evaluate ELI-002 7P in combination with chemotherapy and checkpoint inhibition...

REYKJAVIK, ICELAND (August 10, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...

REYKJAVÍK (10. ágúst 2026) – Alvotech (NASDAQ: ALVO) mun birta uppgjör fyrri árshelmings 2026 þann 19. ágúst nk., eftir lokun markaða í Bandaríkjunum. Fundur til kynningar á uppgjörinu verður sendur...

SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for...

Establishes an integrated global platform spanning biosimilar R&D, manufacturing and commercialization  Adds a major long-term growth pillar and extends Amneal’s growth profile into the 2030s ...